B. Spinnewyn

1.7k citations

30 papers · 1.4k indexed · h-index 20

Impact in

Neurology top 2%
- Neurological Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Parkinson's Disease Mechanisms and Treatments
- Neurological Disorders and Treatments
Complementary and alternative medicine top 0.5%
- Ginkgo biloba and Cashew Applications

Papers in

Neurology 14
- Neurological Disease Mechanisms and Treatments 9
- Cerebrovascular and genetic disorders 4
- Neurological disorders and treatments 3
- Parkinson's Disease Mechanisms and Treatments 3
- Neuroinflammation and Neurodegeneration Mechanisms 3
Complementary and alternative medicine 9
- Ginkgo biloba and Cashew Applications 9

Co-authors: P. Braquet Nicolás G. Bazán F Clostre Krish Chandrasekaran Zara Mehrabian Katy Drieu Gary Fiskum N. Blavet
Journals: Prostaglandins (4 papers)Brain Research (3 papers)European Journal of Pharmacology (2 papers)Journal of Cerebral Blood Flow & Metabolism (2 papers)Biochemical and Biophysical Research Communications (2 papers)
Partner nations: France United States Ireland

In The Last Decade

B. Spinnewyn

29 papers receiving 1.4k citations

Peers

Countries citing papers authored by B. Spinnewyn

Since Specialization

Citations

This map shows the geographic impact of B. Spinnewyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Spinnewyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Spinnewyn more than expected).

Fields of papers citing papers by B. Spinnewyn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Spinnewyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Spinnewyn. The network helps show where B. Spinnewyn may publish in the future.

Co-authorship network

The 25 scholars most cited alongside B. Spinnewyn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Spinnewyn Line = papers co-authored together B. Spinnewyn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Correction: IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates PLoS ONE ·Romina Aron Badin, B. Spinnewyn, Marie‐Claude Gaillard, Caroline Jan, Carole Malgorn, Nadja Van Camp, Daniel Jurewicz, Martine Guillermier, Sabrina Boulet, Anne Bertrand, Marc Savasta, Michel Auguet, Emmanuel Brouillet, Pierre‐Etienne Chabrier, Philippe Hantraye	2013	1
2	IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates PLoS ONE ·Romina Aron Badin, B. Spinnewyn, Marie‐Claude Gaillard, Caroline Jan, Carole Malgorn, Nadja Van Camp, Frédéric Dollé, Martine Guillermier, Sabrina Boulet, Anne Bertrand, Marc Savasta, Michel Auguet, Emmanuel Brouillet, Pierre‐Etienne Chabrier, Philippe Hantraye	2013	15
3	Long-term treatment with standardized Ginkgo biloba Extract (EGb 761) attenuates cognitive deficits and hippocampal neuron loss in a gerbil model of vascular dementia Fitoterapia ·Suh Duk Rok, Denis Carré, B. Spinnewyn, Peter Toth, Sylvie Delaflotte, Bernadette Pignol, Pierre‐Etienne Chabrier, Michel Auguet	2011	31
4	BN82451 attenuates l-dopa-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson’s disease Neuropharmacology ·B. Spinnewyn, Gisèle Mautino, Jean‐Grégoire Marin, علی رضائی, Meghan Engbretson, Eric Ferrandis, Michel Auguet, Pierre‐Etienne Chabrier	2010	12
5	An improved model to investigate the efficacy of antidyskinetic agents in hemiparkinsonian rats Fundamental and Clinical Pharmacology ·B. Spinnewyn, S Rippstein, 郭筱君, L Dawydzik, Pierre‐Etienne Chabrier, Michel Auguet	2010	7
6	Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline European Journal of Pharmacology ·郭筱君, B. Spinnewyn, Sylvie Delaflotte, S Rippstein, L Dawydzik, 肖其华, Linofal Fakhrin, P Chabrier, Michel Auguet	2004	25
7	Neuroprotective Effects of Bilobalide, a Component of Ginkgo biloba Extract (EGb 761®) in Global Brain Ischemia and in Excitotoxicity-induced Neuronal Death Pharmacopsychiatry ·Krish Chandrasekaran, Zara Mehrabian, B. Spinnewyn, Christos Chinopoulos, Katy Drieu, Gary Fiskum	2003	74
8	Phenolic thiazoles as novel orally-active neuroprotective agents Bioorganic & Medicinal Chemistry Letters ·S. Cavirani, L Dawydzik, Saning’o John Sindila, S Rippstein, B. Spinnewyn, 郭筱君, Alain Rolland, Jean‐Grégoire Marin, Dennis Bigg, Caroline Bernardi	2003	59
9	Bilobalide, a component of the Ginkgo biloba extract (EGb 761), protects against neuronal death in global brain ischemia and in glutamate-induced excitotoxicity. PubMed ·Krish Chandrasekaran, Zara Mehrabian, B. Spinnewyn, Christos Chinopoulos, Katy Drieu, Gary Fiskum	2002	34
10	Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia Brain Research ·Krish Chandrasekaran, Zara Mehrabian, B. Spinnewyn, Katy Drieu, Gary Fiskum	2001	89
11	BN 80933 Inhibits F2-isoprostane elevation in focal cerebral ischaemia and hypoxic neuronal cultures Neuroreport ·Jean‐Grégoire Marin, 郭筱君, B. Spinnewyn, Caroline Demerlé-Pallardy, Michel Auguet, Pierre‐Etienne Chabrier	2000	23
12	Changes in [3H]PAF binding and PAF concentrations in gerbil brain after bilateral common carotid artery occlusion: a quantitative autoradiographic study Brain Research ·M.T. Domingo, B. Spinnewyn, P Chabrier, P. Braquet	1994	36
13	The Role of Platelet‐Activating Factor in Cerebral Ischemia and Related Disorders Annals of the New York Academy of Sciences ·P. Braquet, B. Spinnewyn, R. Flaminio, David Hosford, Victor Marcheselli, Magdalena J. Rossowska, Nicolás G. Bazán	1989	19
14	Platelet activating factor as a mediator in cerebral ischemia and related disorders. PubMed ·P. Braquet, B. Spinnewyn, N. Blavet, C Ilham Endarto, Yugang Ma, Frederick Walton Atkinson	1988	11
15	Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils Prostaglandins ·B. Spinnewyn, N. Blavet, F Clostre, Nicolás G. Bazán, (unknown)	1987	103
16	Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: Inhibition of ischemia-reperfusion induced cerebral injury Biochemical and Biophysical Research Communications ·Thomas F. Panetta, Victor L. Marcheselli, P. Braquet, B. Spinnewyn, Nicolás G. Bazán	1987	134
17	Potentiation of the effect of BN 5201, a PAF antagonist by cyclosporine a (CsA) in the cerebral post ischemic phase in gerbils Prostaglandins ·B. Spinnewyn, N. Blavet, P. Braquet	1987	2
18	Effets de l'extrait de Ginkgo biloba sur un modèle d'ischémie cérébrale chez la gerbille. La Presse Médicale ·B. Spinnewyn, M Weadon, F Clostre	1986	13
19	BN 52021 and related compounds: A new series of highly specific PAF-acether receptor antagonists isolated from Ginkgo biloba L. Blood & Vessel ·P. Braquet, B. Spinnewyn, M. Braquet, R.H. Bourgain, John E. Taylor, Alan H. Colen, М П Харитонова	1985	173
20	Effects of Agents Used in the Pharmacotherapy of Cerebrovascular Disease on the Oxygen Consumption of Isolated Cerebral Mitochondria Journal of Cerebral Blood Flow & Metabolism ·Jean-Pierre Nowicki, Eric T. MacKenzie, B. Spinnewyn	1982	21

About B. Spinnewyn

B. Spinnewyn is a scholar working on Neurology, Complementary and alternative medicine, Neurology, Cellular and Molecular Neuroscience and Physiology, having authored 30 papers that have together received 1.4k indexed citations. Recurring topics across this work include Neurological Disease Mechanisms and Treatments (9 papers), Ginkgo biloba and Cashew Applications (9 papers), Neuroscience and Neuropharmacology Research (5 papers), Cerebrovascular and genetic disorders (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Neurological disorders and treatments (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). The work is most often cited by research in Neurology (506 citations), Complementary and alternative medicine (405 citations), Biochemistry (110 citations), Cellular and Molecular Neuroscience (258 citations) and Neurology (197 citations). B. Spinnewyn has collaborated with scholars based in France, United States and Ireland. Frequent co-authors include P. Braquet, Nicolás G. Bazán, F Clostre, Krish Chandrasekaran, Zara Mehrabian, Katy Drieu, Gary Fiskum, N. Blavet, E. Pirotzky and Michel Auguet. Their work appears in journals such as Prostaglandins, Brain Research, European Journal of Pharmacology, Journal of Cerebral Blood Flow & Metabolism and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact